Geneoscopy is a life sciences company focused on developing noninvasive diagnostic tests for gastrointestinal health, including colorectal cancer screening and other GI disease applications.
Typically supports policies that expand access to preventive screening, diagnostic innovation, precision medicine, and reimbursement or regulatory pathways for medical diagnostics and laboratory-developed testing.
Primarily funded through private venture and growth equity investment, along with commercial revenue and strategic partnerships.
Co-founder and CEO Andrew Barnell; Bio-Rad Laboratories (strategic/corporate relationship); university and biopharmaceutical research partners.
Private company